cysteine has been researched along with caffeine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Afzal, SM; Kesavan, PC | 1 |
| Britt, BA; de Leon, S; Derdemezi, J; Duff, CL; Fujii, J; Gillard, EF; Khanna, VK; MacLennan, DH; Otsu, K; Worton, RG | 1 |
| Ardlie, NG; Glew, G; Schultz, BG; Schwartz, CJ | 1 |
| Cheng, YC; Nations, C | 1 |
| Hori, M; Kamada, T; Kimura, Y; Kuzuya, T; Nishida, K; Otsu, K; Tada, M | 1 |
| Blair, DC; Holohan, PD; Lehmann, DF | 1 |
| Kesavan, PC; Sah, NK | 1 |
| Lennarz, WJ; Luz, JM | 1 |
| Kato, BM; Rubel, EW | 1 |
| Chen, SR; Fruen, BR; Li, P; Louis, CF; Zhao, F | 1 |
| Alsene, K; de Wit, H; Deckert, J; Sand, P | 1 |
| Peng, Y; Tang, F; Weisman, LS | 1 |
| Allen, PD; Ernst-Russell, MA; Lango, J; Lee, EH; Ma, J; Pessah, IN; Phimister, AJ; Takeshima, H | 1 |
| Haining, RL; Hernandez, A; Jones, TM | 1 |
| Aoyama, K; Bhadhprasit, W; Kinoshita, C; Matsumura, N; Nakaki, T | 1 |
| Aoyama, K; Matsumura, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for cysteine and caffeine
| Article | Year |
|---|---|
Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Brain; Caffeine; Cysteine; Excitatory Amino Acid Transporter 3; Glutathione; Humans; Neuroprotection; Neuroprotective Agents; Parkinson Disease; Purines; Receptor, Adenosine A2A; Theophylline; Uric Acid | 2023 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for cysteine and caffeine
| Article | Year |
|---|---|
Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus.
Topics: Adult; Anti-Infective Agents; Caffeine; Cysteine; Drug Hypersensitivity; Female; HIV Infections; Humans; Male; Oxidation-Reduction; Phosphodiesterase Inhibitors; Pilot Projects; Prospective Studies; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.
Topics: Adult; Animals; Anxiety; Caffeine; Central Nervous System Stimulants; Cysteine; Double-Blind Method; Female; Genetic Variation; Genotype; Humans; Hybrid Vigor; Male; Neuropsychological Tests; Pain Measurement; Personality Inventory; Polymorphism, Genetic; Receptor, Adenosine A2A; Receptors, Purinergic P1; Sequence Analysis, DNA; Tandem Repeat Sequences; Threonine; Time Factors | 2003 |
13 other study(ies) available for cysteine and caffeine
| Article | Year |
|---|---|
Letter: Dependence of chemical radioprotection on the stability of radiation-induced oxygen-sensitive sites.
Topics: Caffeine; Cobalt Radioisotopes; Cysteine; Gamma Rays; Oxygen; Potassium Permanganate; Radiation Effects; Radiation-Protective Agents; Seeds | 1975 |
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.
Topics: Adolescent; Amino Acid Sequence; Arginine; Base Sequence; Caffeine; Cloning, Molecular; Cysteine; Exons; Female; Halothane; Humans; Male; Malignant Hyperthermia; Molecular Sequence Data; Muscle Proteins; Mutation; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Receptors, Cholinergic; Restriction Mapping; Ryanodine Receptor Calcium Release Channel; White People | 1991 |
Inhibition and reversal of platelet aggregation by methyl xanthines.
Topics: Adenine Nucleotides; Aminophylline; Blood Coagulation; Blood Platelets; Caffeine; Cysteine; Edetic Acid; Ethylenediamines; Glutathione; Hydrogen-Ion Concentration; In Vitro Techniques; Sodium Salicylate; Theobromine; Xanthines | 1967 |
Stabilization and enhancement of glutamate decarboxylase activity in extracts of the slime mold, Physarum polycephalum.
Topics: Aluminum; Ascorbic Acid; Biochemical Phenomena; Biochemistry; Caffeine; Carboxy-Lyases; Cyanides; Cysteine; Enzyme Activation; Glutamates; Myxomycetes; Phenylthiourea; Potassium; Time Factors | 1971 |
The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
Topics: Amino Acid Sequence; Animals; Arginine; Blotting, Western; Caffeine; Calcium; Calcium Channels; Cell Line; Cysteine; Drug Hypersensitivity; Gene Library; Halothane; Intracellular Membranes; Malignant Hyperthermia; Mice; Microsomes; Muscle Proteins; Muscles; Point Mutation; Poly A; Rabbits; RNA; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Transfection | 1994 |
Probing tenability of biochemical vis-a-vis physicochemical interpretations of modulation of radiation damage by caffeine and cysteine in barley.
Topics: Caffeine; Catalase; Chemical Phenomena; Chemistry, Physical; Cysteine; Hordeum; Hydrogen Peroxide; Radiation-Protective Agents; RNA, Plant | 1996 |
The nonactive site cysteine residues of yeast protein disulfide isomerase are not required for cell viability.
Topics: Amino Acid Sequence; Animals; Binding Sites; Caffeine; Cysteine; Dithiothreitol; Mammals; Point Mutation; Protein Disulfide-Isomerases; Saccharomyces cerevisiae; Serine | 1998 |
Glutamate regulates IP3-type and CICR stores in the avian cochlear nucleus.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alanine; Animals; Benzoates; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Chelating Agents; Chick Embryo; Cochlear Nucleus; Cyclic AMP; Cycloleucine; Cysteine; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Fura-2; Gallic Acid; Glutamic Acid; Glycine; Ibotenic Acid; Inositol 1,4,5-Trisphosphate Receptors; Ion Channel Gating; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Receptors, Cytoplasmic and Nuclear; Ryanodine; Second Messenger Systems; Thionucleotides | 1999 |
Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.
Topics: Adenine; Animals; Arginine; Binding Sites; Caffeine; Calcium; Cell Line; Central Nervous System Stimulants; Cloning, Molecular; Cysteine; Dantrolene; DNA, Complementary; Genes, Dominant; Humans; Inhibitory Concentration 50; Kinetics; Magnesium; Magnesium Chloride; Muscle Relaxants, Central; Muscle, Skeletal; Myocardium; Protein Binding; Protein Isoforms; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Signal Transduction; Strontium; Swine; Transfection | 2001 |
Palmitoylation plays a role in targeting Vac8p to specific membrane subdomains.
Topics: Amino Acid Sequence; Caffeine; Cell Membrane; Cell Nucleus; Cysteine; Drug Resistance, Fungal; Fungal Proteins; Lipoproteins; Membrane Microdomains; Membrane Proteins; Molecular Sequence Data; Phosphodiesterase Inhibitors; Protein Processing, Post-Translational; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Vacuoles; Vesicular Transport Proteins | 2006 |
Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols.
Topics: Animals; Caffeine; Calcium; Cysteine; Magnesium; Membrane Proteins; Microsomes; Models, Chemical; Oxidation-Reduction; Protein Binding; Protein Conformation; Rabbits; Ryanodine Receptor Calcium Release Channel; Sulfhydryl Compounds; Trypsin | 2007 |
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
Topics: Caffeine; Cysteine; Dopamine; Iron; Melanins; Nicotine; Oxidopamine; Parkinson Disease; Polymerization; Spectrometry, Fluorescence | 2016 |
A purine derivative, paraxanthine, promotes cysteine uptake for glutathione synthesis.
Topics: Animals; Caffeine; Cysteine; Glutathione; HEK293 Cells; Humans; Hydrogen Peroxide; Mice; Neuroblastoma; Theophylline; Uric Acid | 2023 |